Skip to main content

Table 4 Presence of antibiotic resistance genes (ARGs) at time points during the first year of life

From: Longitudinal assessment of antibiotic resistance gene profiles in gut microbiomes of infants at risk of eczema

  Number of subjects#% of subjects with ARG present at time pointsNumber of subjects*% of subjects with ARG present at time points
Antibiotic resistance genotypeARGW3W3 and M12W3 and M12W3W3 to M3W3 to M6W3 to M12W3 to M3W3 to M6W3 to M12
FosfomycinfosA211152%876488%75%50%
Beta-lactamblaZ21210%711014%14%0%
Aminoglycosideaac(6′)-aph(2″)11545%510020%0%0%
Macrolidelsa(A)13215%5531100%60%20%
QuinoloneoqxB14429%541180%20%20%
Macrolideerm(B)131185%422250%50%50%
Macrolideerm(X)6583%432175%50%25%
Macrolidemef(A)1515100%4433100%75%75%
Macrolide, Lincosamide and Streptogramin Bmsr(D)1414100%4422100%50%50%
Tetracyclinetet(M)151173%421150%25%25%
Aminoglycosideaph(3′)-III7571%321167%33%33%
Sulphonamidesul28450%3322100%67%67%
Tetracyclinetet(O)6467%3332100%100%67%
Tetracyclinetet(Q)5480%3333100%100%100%
Tetracyclinetet(W)111091%3333100%100%100%
Beta-lactamblaTEM-1b9667%2221100%100%50%
AminoglycosideaadE11100%1100100%0%0%
  1. # subjects with stool samples at both week 3 and month 12 (N = 22). *subjects with stool samples at all timepoints (N = 8)